Roopa Industries Ltd

Roopa Industries Ltd (ROOPAIND) is a micro-cap Healthcare company valued at ₹34 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Roopa Industries Ltd last traded at ₹44.99, modestly up 1.31% on the day.

Recent developments

On 2026-09-30, the promoter holding remained at 48.03%, with no significant changes reported. The company's debt to equity ratio stands at 1.76, indicating a high level of leverage. The latest quarter showed no change in net profit despite a revenue decline.

Financial performance

The company's revenue grew 5.6% annually but fell 5.0% in the latest quarter compared to the same period a year earlier. Net profit turned negative for the first time in the latest quarter, with annual net profit dropping to ₹0 crore from ₹2 crore. Margins have collapsed, with the net profit margin falling to 0.1% from 1.7% a year ago.

Valuation multiples

The stock trades at 23.3 times earnings, a discount to the Healthcare median of 32.0, 2.05 times book value.

Things to watch

The company reported an annual net profit of ₹0 crore, a sharp decline of 96.1% from the previous year. The net profit margin has fallen to 0.1%, a drop of 1.6 percentage points. The debt to equity ratio of 1.76 suggests high leverage, which could increase financial risk.

Where it stands

Roopa Industries Ltd ended the latest quarter with revenue of ₹33 crore and net profit of ₹0 crore, showing no improvement from the previous year. The company's net profit margin has collapsed to 0.1%, and its debt to equity ratio remains at 1.76. The stock is 30.0% below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.